Contact Information

160 Robinson Rd, #14-04
Sit Rd, SBF Center, Singapore 068914

Doctor Anywhere, a tech-driven healthcare provider based in Singapore, recently announced the completion of an extension round for their Series C1 funding, securing an additional $40.8M.

  • Previous Funding: This funding comes barely a year after they closed their $38.8M Series C1 round and follows their original Series C funding of $65.7M in August 2021. With this, the total capital amassed by Doctor Anywhere now stands at an impressive $180.8M.
  • Expansion Plans: The funds are primarily earmarked for expanding the company’s reach into secondary care, particularly in the wake of integrating Asian Healthcare Specialists (AHS) into their business. AHS, acquired by Doctor Anywhere in December 2022, is a network of 14 medical specialists operating across 12 specialist clinics.
  • Product Scaling: Alongside expansion efforts, Doctor Anywhere plans to invest in scaling their healthcare innovation initiatives such as predictive healthcare needs assessment, streamlined appointment scheduling, and improved accessibility and efficiency of healthcare services.
  • Profitability: Doctor Anywhere’s chief executive officer, Wai Mun Lim, remains committed to attaining break-even status by the end of 2023.

Founded in 2017, Doctor Anywhere began as a telemedicine platform but has since expanded its scope to serve over 2.5 million users across six Southeast Asian countries. With the onset of Covid-19, the company was the first in Singapore to launch online-supervised antigen rapid testing (ART) in January 2020.

client banner image


Leave a Reply

Your email address will not be published. Required fields are marked *